In the previous cycle we characterized the ability of certain benzodiazepines, in cooperation with decreased extracellular pH, to regulate airway smooth muscle (ASM) signaling and function via activation of the proton- sensing G protein-coupled receptor (GPCR) OGR1 (Ovarian cancer G-protein coupled receptor 1 aka GPR68). Importantly, we discovered that the multiple signaling pathways activated downstream of OGR1 could be selectively activated (i.e., biased) to produce differential effects on ASM contraction and proliferation. In this second cycle we propose to: 1) delineate the mechanisms by which the biasing of OGR1 signaling occurs; 2) detail an additional, mitochondrial-dependent effector arm of benzodiazepines that also inhibits ASM contraction; and 3) employ modeling to develop more efficacious benzodiazepine-like drugs that target these mechanisms. These goals will be achieved through 3 Specific Aims.
In Aim 1 we will employ cell-based and integrative models of ASM contraction to clarify the how different benzodiazepines promote specific OGR1- and peripheral benzodiazepine receptor- signaling to regulate ASM contraction.
In Aim 2 will establish the mechanistic basis of biased OGR1 signaling by assessing structure-function properties of OGR1 that dictate G protein coupling, and the biasing function of arrestins.
In Aim 3 in collaboration with Core A we will employ molecular modeling to design new allosteric modulators to bias OGR1 signaling towards Gs/cAMP/PKA pathway activation and the associated therapeutic benefits, using the signaling and functional assays employed in Aims 1 and 2 to guide development and identify the most efficacious drugs. By establishing mechanisms mediating qualitative signaling by OGR1 and developing new agents that optimally bias OGR1 and promote bronchodilation, we will significantly advance the fields of both receptor biology and asthma therapeutics.

Public Health Relevance

We have discovered that certain benzodiazepines have the ability to function as bronchodilators by acting on two poorly understood proteins expressed in airway smooth muscle: the cell surface receptor termed OGR1 and the mitochondria-associated proton termed the peripheral benzodiazepine receptor. We propose studies to better understand how these proteins function to relax airway smooth muscle and thereby inhibit the airway closure that occurs in patients with asthma. We will also take advantage of the unique resources provided by the Program Project grant to develop new, better benzodiazepine-like drugs to improve the likelihood of realizing these drugs as approved asthma therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL114471-07
Application #
9998009
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Noel, Patricia
Project Start
2013-07-15
Project End
2024-07-31
Budget Start
2020-08-01
Budget End
2021-07-31
Support Year
7
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Rutgers University
Department
Type
DUNS #
078816195
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Lo, Dennis; Kennedy, Joshua L; Kurten, Richard C et al. (2018) Modulation of airway hyperresponsiveness by rhinovirus exposure. Respir Res 19:208
Kim, Donghwa; Cho, Soomin; Woo, Jung A et al. (2018) A CREB-mediated increase in miRNA let-7f during prolonged ?-agonist exposure: a novel mechanism of ?2-adrenergic receptor down-regulation in airway smooth muscle. FASEB J 32:3680-3688
Huang, Yapei; Xie, Yan; Jiang, Haihong et al. (2018) Upregulated P-Rex1 exacerbates human airway smooth muscle hyperplasia in asthma. J Allergy Clin Immunol :
Manorak, Wichayapha; Idahosa, Chizobam; Gupta, Kshitij et al. (2018) Upregulation of Mas-related G Protein coupled receptor X2 in asthmatic lung mast cells and its activation by the novel neuropeptide hemokinin-1. Respir Res 19:1
An, Steven S; Liggett, Stephen B (2018) Taste and smell GPCRs in the lung: Evidence for a previously unrecognized widespread chemosensory system. Cell Signal 41:82-88
Winchell, Caylin G; Dragan, Amanda L; Brann, Katelynn R et al. (2018) Coxiella burnetii Subverts p62/Sequestosome 1 and Activates Nrf2 Signaling in Human Macrophages. Infect Immun 86:
Chaturvedi, Madhu; Schilling, Justin; Beautrait, Alexandre et al. (2018) Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors. Trends Biochem Sci 43:533-546
Tliba, Omar; Panettieri Jr, Reynold A (2018) Paucigranulocytic asthma: Uncoupling of airway obstruction from inflammation. J Allergy Clin Immunol :
Pera, Tonio; Deshpande, Deepak A; Ippolito, Michael et al. (2018) Biased signaling of the proton-sensing receptor OGR1 by benzodiazepines. FASEB J 32:862-874
Ojiaku, Christie A; Cao, Gaoyuan; Zhu, Wanqu et al. (2018) TGF-?1 Evokes Human Airway Smooth Muscle Cell Shortening and Hyperresponsiveness via Smad3. Am J Respir Cell Mol Biol 58:575-584

Showing the most recent 10 out of 68 publications